25 January 2018

Task Force Annual Report - HIV


he PVRI HIV-associated Pulmonary Hypertension Task Force has been an important Task Force of the PVRI since its creation in 2006/7.

The Task Force was represented at various PVRI conferences over the years, participating in posters presentations, lectures and webinars, thus increasing the awareness of infectious disease specialists dealing with HIV on this uncommon, but dramatic manifestation.

The main aim of the Task Force was to collaborate with some of the most important infectious disease societies, such as the ESCMID (European Society of Clinical Microbiology and Infectious Diseases), on joint issues. In 2010, during the ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) Conference in Vienna, Austria, we organised a full PVRI-ECCMID joint session with PVRI and ECCMID speakers. A special issue on ‘Pulmonary Hypertension and Infections of Clinical Microbiology’ was later published, with all authors being PVRI members and the editor being the Task Force leader. Over the years, a lot of research on HIV-associated pulmonary hypertension was generated by the Task Force, which resulted in the publication of around 30 papers in various peer reviewed journals.

Since HIV infection is not decreasing in terms of new infections, our mission remains to increase the awareness of HIV-associated PH and to collaborate with HIV specialists, pulmonologists, cardiologists and basic scientists from all over the world to discuss current needs and future chemical and biomedical research directions. Moreover, over the next 10 years we would like to measure the impact of the most powerful antiretroviral therapies on the occurrence of PH, and to create and nurture international collaborations.

In order to identify specific gaps in knowledge and resources available to clinicians caring for HIV associated PH, we would like to conduct a survey with all PVRI members and the wider PVRI network, as well as to revamp the HIV-PH Task Force website to include information about registries of HIV-associated hypertension in countries where there is a PVRI presence. Furthermore, a vital effort will be the recruitment of new international members to the HIV Task Force in order to increase our reach and impact.

Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI